Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study
about
Impact of ART on the fertility of HIV-positive women in sub-Saharan AfricaThe role of family planning in achieving safe pregnancy for serodiscordant couples: commentary from the United States government's interagency task force on family planning and HIV service integrationDrug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIVBrief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data.Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 WeeksContraceptive challenges in adolescents living with or at risk of HIV.Factors Associated with Hormonal and Intrauterine Contraceptive Use among HIV-Infected Men and Women in Lilongwe, Malawi: A Cross-Sectional StudyDrug interactions between hormonal contraceptives and antiretrovirals.Bleeding patterns of HIV-infected women using an etonogestrel-releasing contraceptive implant and efavirenz-based or lopinavir/ritonavir-based antiretroviral therapy.Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy.Concomitant contraceptive implant and efavirenz use in women living with HIV: perspectives on current evidence and policy implications for family planning and HIV treatment guidelines.Dapivirine vaginal ring use does not diminish the effectiveness of hormonal contraception.The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine.Current and future contraceptive options for women living with HIV.Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals?Reproductive intentions and family planning practices of pregnant HIV-infected Malawian women on antiretroviral therapy.Reduced Effectiveness of Contraceptive Implants for Women Taking the Antiretroviral Efavirenz (EFV): Still Good Enough and for How Long?Physiologically based pharmacokinetic modelling prediction of the effects of dose adjustment in drug-drug interactions between levonorgestrel contraceptive implants and efavirenz-based ART.Contraceptive use and pregnancy rates among women receiving antiretroviral therapy in Malawi: a retrospective cohort study.International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UKEvidence of patients' challenges and barriers related to usage of Implanon®: scoping review protocolEffect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial
P2860
Q28069883-3D4C85F5-FB06-4085-BCA8-E62DC8641DC9Q33769798-6606E2ED-84ED-4F42-A887-55023CD73FE9Q34538556-23949ECE-77CB-4349-AD42-8E0D1EA4761CQ36343568-ED679294-9B47-4DC0-8BFA-36200D712572Q36635690-18207F97-3C85-42E4-BADB-E77F4FF98C0EQ37136261-C303EC9A-BD7D-490F-A2AA-BD59C160E704Q37236034-6624381A-7DC4-4D06-A65E-05A4D568FD82Q37735345-7733ABE2-085E-42FE-8967-6EA3A62CDA28Q38407716-6F219128-D69E-4B26-9EB5-6CD1F564B253Q38686382-0F8FFEDE-B9FA-4800-8E9C-AE698EBF0A10Q38771869-ECD2CE58-F7AA-48F6-A79D-461B07FA588EQ38850149-39A645C0-6E89-44C1-B575-1EF283E38E77Q38851258-760B8604-CFDE-4171-BA02-302101E0E926Q40048203-5C1286EC-0645-4684-8D92-68813D28FE4AQ40515915-5C37598A-98A3-49BA-BD89-476E5B827E7BQ40791379-CC7BF4D8-87B1-4917-A4C5-6A630DB25DDAQ42851887-9D3A113A-C440-41CB-8936-C95FC33469C7Q48524975-EBC32FAC-4530-4DEE-9340-984B12BC2514Q49855560-8F16EE83-89C6-48CA-AEEC-AAEFBE3DA92DQ56762706-C00058B1-66CE-4FC4-849E-4ED1CF76F988Q57473210-F4EF6285-9CBE-48D6-A092-CAF6ECEEAEB0Q58774718-7044A06F-1816-44AF-B7E3-F2E537AAA4A4
P2860
Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Pregnancy rates in HIV-positiv ...... : a retrospective cohort study
@ast
Pregnancy rates in HIV-positiv ...... : a retrospective cohort study
@en
Pregnancy rates in HIV-positiv ...... : a retrospective cohort study
@nl
type
label
Pregnancy rates in HIV-positiv ...... : a retrospective cohort study
@ast
Pregnancy rates in HIV-positiv ...... : a retrospective cohort study
@en
Pregnancy rates in HIV-positiv ...... : a retrospective cohort study
@nl
prefLabel
Pregnancy rates in HIV-positiv ...... : a retrospective cohort study
@ast
Pregnancy rates in HIV-positiv ...... : a retrospective cohort study
@en
Pregnancy rates in HIV-positiv ...... : a retrospective cohort study
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
Pregnancy rates in HIV-positiv ...... : a retrospective cohort study
@en
P2093
Cinthia Blat
Jill Hagey
Monica Gandhi
Rena C Patel
Sara J Newmann
Starley B Shade
P2860
P304
P3181
P356
10.1016/S2352-3018(15)00184-8
P407
P5008
P577
2015-11-01T00:00:00Z